wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38263514-56F2CFC3-4D81-4B2B-92E0-ECC148C1CCD8
Q38263514-56F2CFC3-4D81-4B2B-92E0-ECC148C1CCD8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38263514-56F2CFC3-4D81-4B2B-92E0-ECC148C1CCD8
State of the art in the treatment of systemic vasculitides.
P2860
Q38263514-56F2CFC3-4D81-4B2B-92E0-ECC148C1CCD8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38263514-56F2CFC3-4D81-4B2B-92E0-ECC148C1CCD8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e468ef9b03df3378b57e71be21ff1369ac001076
P2860
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.